Payer Roadblocks in Pediatric Atopic Dermatitis Care
Expensive, newer therapies and a lack of pediatric data are roadblocks to advancing treatment for pediatric atopic dermatitis, according to Lawrence Eichenfield, M.D.
“It seems to be that roadblocks or speed bumps are being put in the way for newer therapies,”
Newer therapies include non-steroidal agents, which offer longer treatment windows with fewer side effects than topical steroids. Eichenfield also mentioned the lack of pediatric data, which stalls approvals.
- High cost of newer therapies
- Lack of pediatric data
Author's summary: Roadblocks hinder pediatric atopic dermatitis treatment.